21-Gene recurrence score decreases receipt of chemotherapy in ER+ early-stage breast cancer: an analysis of the NCDB 2010–2013

The purpose of this study was to determine if receipt of chemotherapy was associated with utilization of the 21-gene recurrence score assay (RS assay) or with recurrence score (RS) in eligible patients. Using the National Cancer Data Base (NCDB), we identified female patients eligible for RS assay b...

Descripción completa

Detalles Bibliográficos
Autores principales: Parsons, Benjamin M., Landercasper, Jeffrey, Smith, Angela L., Go, Ronald S., Borgert, Andrew J., Dietrich, Leah L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012154/
https://www.ncbi.nlm.nih.gov/pubmed/27507245
http://dx.doi.org/10.1007/s10549-016-3926-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012154/
https://www.ncbi.nlm.nih.gov/pubmed/27507245
http://dx.doi.org/10.1007/s10549-016-3926-5

Ejemplares similares